BW
Brendan Winslow
Chief Financial OfficerMr. Brendan Winslow is Chief Financial Officer of Atrium Therapeutics, Inc. Mr. Winslow has served as Senior Vice President of Finance at Avidity since 2024. Before joining Avidity, Mr. Winslow served as Vice President, Strategic Finance at Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) between 2020 and 2024. Mr. Winslow also held leadership roles at Acadia Pharmaceuticals, Synchrony Financial, PepsiCo and Baxter International, supporting global operations and strategic finance initiatives. Mr. Winslow holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor of Science in Finance from Miami University and is a Certified Management Accountant.
Positions
- Company NameAtrium Therapeutics, Inc.Stock CodeRNAPositionChief Financial OfficerColleagues
- KPKathleen P. GallagherPresident, CEO & Director
- SBSarah BoyceIndependent Chair of the Board of Director
- HYHusam YounisChief Scientific Officer
- SKStephanie KenneyChief Corporate Affairs Officer
- SGSteven George HughesChief Medical Officer
- CBCarsten BoessIndependent Director
- TETroy Edward WilsonIndependent Director
- WMW. Michael F. FlanaganIndependent Director
